Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor

Hidetoshi Nakatake, Hisao Ekimoto, Mariko Aso, Atsushi Ogawa, Asami Yamaguchi, Hiroshi Suemune

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Bisphosphonates have high affinity for hydroxyapatite (HA), which is abundantly present in bone. Also, platinum complexes are known that have a wide spectrum of antitumor activities. The conjugate of bisphosphonate and a platinum complex might have HA affinity and antitumor activity, and become a drug for metastatic bone tumor. In this study, the authors synthesized platinum complexes that had dialkyl bisphosphonic acid as a ligand, and evaluated the possibility of the synthesized complexes as a drug for metastatic bone tumor. The synthesized dialkyl bisphosphonate platinum(II) complex was characterized, and its stability in an aqueous solution was also confirmed. The synthesized platinum complex showed higher HA affinity than other platinum complexes such as cisplatin and carboplatin in an experiment of adsorption to HA. In vitro, the platinum complex showed tumor growth inhibitory effect stronger than or equal to cisplatin, which is the most commonly used antitumor agent. Moreover, the platinum complex showed a bone absorption inhibitory effect on the osteoclast. These results suggest potential of dialkyl bisphosphonate platinum(II) complexes as a drug for metastatic bone tumor.

Original languageEnglish
Pages (from-to)710-713
Number of pages4
JournalChemical and Pharmaceutical Bulletin
Volume59
Issue number6
DOIs
Publication statusPublished - Jun 6 2011

Fingerprint

Diphosphonates
Platinum
Tumors
Bone
Bone and Bones
Pharmaceutical Preparations
Durapatite
Neoplasms
Cisplatin
Carboplatin
Osteoclasts
Antineoplastic Agents
Adsorption
Ligands
Acids
Growth

All Science Journal Classification (ASJC) codes

  • Drug Discovery
  • Chemistry(all)

Cite this

Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor. / Nakatake, Hidetoshi; Ekimoto, Hisao; Aso, Mariko; Ogawa, Atsushi; Yamaguchi, Asami; Suemune, Hiroshi.

In: Chemical and Pharmaceutical Bulletin, Vol. 59, No. 6, 06.06.2011, p. 710-713.

Research output: Contribution to journalArticle

Nakatake, Hidetoshi ; Ekimoto, Hisao ; Aso, Mariko ; Ogawa, Atsushi ; Yamaguchi, Asami ; Suemune, Hiroshi. / Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor. In: Chemical and Pharmaceutical Bulletin. 2011 ; Vol. 59, No. 6. pp. 710-713.
@article{fe63fd10a1ca4bf9b51ac569e50ede0c,
title = "Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor",
abstract = "Bisphosphonates have high affinity for hydroxyapatite (HA), which is abundantly present in bone. Also, platinum complexes are known that have a wide spectrum of antitumor activities. The conjugate of bisphosphonate and a platinum complex might have HA affinity and antitumor activity, and become a drug for metastatic bone tumor. In this study, the authors synthesized platinum complexes that had dialkyl bisphosphonic acid as a ligand, and evaluated the possibility of the synthesized complexes as a drug for metastatic bone tumor. The synthesized dialkyl bisphosphonate platinum(II) complex was characterized, and its stability in an aqueous solution was also confirmed. The synthesized platinum complex showed higher HA affinity than other platinum complexes such as cisplatin and carboplatin in an experiment of adsorption to HA. In vitro, the platinum complex showed tumor growth inhibitory effect stronger than or equal to cisplatin, which is the most commonly used antitumor agent. Moreover, the platinum complex showed a bone absorption inhibitory effect on the osteoclast. These results suggest potential of dialkyl bisphosphonate platinum(II) complexes as a drug for metastatic bone tumor.",
author = "Hidetoshi Nakatake and Hisao Ekimoto and Mariko Aso and Atsushi Ogawa and Asami Yamaguchi and Hiroshi Suemune",
year = "2011",
month = "6",
day = "6",
doi = "10.1248/cpb.59.710",
language = "English",
volume = "59",
pages = "710--713",
journal = "Chemical and Pharmaceutical Bulletin",
issn = "0009-2363",
publisher = "The Pharmaceutical Society of Japan",
number = "6",

}

TY - JOUR

T1 - Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor

AU - Nakatake, Hidetoshi

AU - Ekimoto, Hisao

AU - Aso, Mariko

AU - Ogawa, Atsushi

AU - Yamaguchi, Asami

AU - Suemune, Hiroshi

PY - 2011/6/6

Y1 - 2011/6/6

N2 - Bisphosphonates have high affinity for hydroxyapatite (HA), which is abundantly present in bone. Also, platinum complexes are known that have a wide spectrum of antitumor activities. The conjugate of bisphosphonate and a platinum complex might have HA affinity and antitumor activity, and become a drug for metastatic bone tumor. In this study, the authors synthesized platinum complexes that had dialkyl bisphosphonic acid as a ligand, and evaluated the possibility of the synthesized complexes as a drug for metastatic bone tumor. The synthesized dialkyl bisphosphonate platinum(II) complex was characterized, and its stability in an aqueous solution was also confirmed. The synthesized platinum complex showed higher HA affinity than other platinum complexes such as cisplatin and carboplatin in an experiment of adsorption to HA. In vitro, the platinum complex showed tumor growth inhibitory effect stronger than or equal to cisplatin, which is the most commonly used antitumor agent. Moreover, the platinum complex showed a bone absorption inhibitory effect on the osteoclast. These results suggest potential of dialkyl bisphosphonate platinum(II) complexes as a drug for metastatic bone tumor.

AB - Bisphosphonates have high affinity for hydroxyapatite (HA), which is abundantly present in bone. Also, platinum complexes are known that have a wide spectrum of antitumor activities. The conjugate of bisphosphonate and a platinum complex might have HA affinity and antitumor activity, and become a drug for metastatic bone tumor. In this study, the authors synthesized platinum complexes that had dialkyl bisphosphonic acid as a ligand, and evaluated the possibility of the synthesized complexes as a drug for metastatic bone tumor. The synthesized dialkyl bisphosphonate platinum(II) complex was characterized, and its stability in an aqueous solution was also confirmed. The synthesized platinum complex showed higher HA affinity than other platinum complexes such as cisplatin and carboplatin in an experiment of adsorption to HA. In vitro, the platinum complex showed tumor growth inhibitory effect stronger than or equal to cisplatin, which is the most commonly used antitumor agent. Moreover, the platinum complex showed a bone absorption inhibitory effect on the osteoclast. These results suggest potential of dialkyl bisphosphonate platinum(II) complexes as a drug for metastatic bone tumor.

UR - http://www.scopus.com/inward/record.url?scp=79957874301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957874301&partnerID=8YFLogxK

U2 - 10.1248/cpb.59.710

DO - 10.1248/cpb.59.710

M3 - Article

VL - 59

SP - 710

EP - 713

JO - Chemical and Pharmaceutical Bulletin

JF - Chemical and Pharmaceutical Bulletin

SN - 0009-2363

IS - 6

ER -